| Application no. and date | 11764764.4 (espacenet) (Federated) (European Patent Register), 20111007 | | Patent/reg. no. and date | DK/EP 2625199, 20171122 | | Publication date | 20130814 | | Priority no. and date | US 391388 P, 20101008 | | EP pub. no. and date |
EP 2625199 20130814 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/156562 | | Inventor | GUETTNER, Achim, Novartis Pharma AG
Postfach
CH-4002 Basel, CH,
MACHACEK, Matthias, Novartis Pharma AG
Postfach
CH-4002 Basel, CH,
PAPAVASSILIS, Charis, Novartis Pharma AG
Postfach
CH-4002 Basel, CH,
SANDER, Oliver, Novartis Pharma AG
Postfach
CH-4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 16/24 (2006.01) | | Title | Fremgangsmåde til behandling af psoriasis ved anvendelse af IL-17 antagonister | | Int. application no. | EP2011067522 | | Int. publication no. | WO2012045848 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
